CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shenzhen Bioeasy Biotechnology Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shenzhen Bioeasy Biotechnology Co Ltd
#2-1 Liuxian 1st Rd, Baoan Dist
Phone: +86 75523095742p:+86 75523095742 Shenzhen, GNG  518126  China Ticker: 300942300942
Business Summary
Shenzhen Bioeasy Biotechnology Co Ltd is a China-based company primarily engaged in the research, development, production and sales of rapid testing reagents. The Company operates two main businesses. The food safety rapid testing business is mainly engaged in the research, development, production and sales of rapid food safety testing reagents and instruments, as well as providing related rapid testing services. The rapid testing reagent products mainly include colloidal gold immunochromatographic test strips, enzyme-linked immunosorbent assay (ELISA) kits, physicochemical reagents, fluorescent polymerase chain reaction (PCR) kits and nucleic acid extraction kits. The animal diagnostics business is mainly engaged in the research, development, production and sales of testing reagents and instruments for commercial animals and companion animals. The Company is also engaged in the provision of in vitro diagnostic reagents and instruments.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
8071 Medical laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager ZhaoliXiao 50 4/1/2024 7/29/2022
Chief Financial Officer KaiWan 42 9/26/2023 12/28/2021
Deputy General Manager, Secretary of the Board, Director WentianLi 32 11/24/2023 9/26/2023
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 480 (As of 12/31/2024)
Outstanding Shares: 405,068,764 (As of 12/3/2025)
Shareholders: 18,442
Stock Exchange: SHE
Fax Number: +86 75527948417


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, February 3, 2026